News & Events

ASU researchers address a primary cause of treatment failure for pancreatic cancer

January 10, 2019

As the second leading cause of death worldwide, cancer is a focal point in both clinical research and health care fields, but not all cancers are created equal. While some cancers are now much less deadly due to recent medical advances, other aggressive cancers remain highly resistant to currently available therapies. This therapy resistance is a leading cause of cancer-associated death. Pancreatic cancer is an extreme example of this effect, and therapy resistance is a major reason why only...

Proteomics may have saved my mother's life. And it may yet save mine

December 14, 2018

The New York Times THE SERGEANT WITH the Mount Crested Butte Police Department in Colorado appeared and I was with my wife and our two young children, ages 2 and 7, at Lake Irwin, a remote campsite at 10,200 feet in the Rocky Mountains. When the officer stepped out of his S.U.V. cruiser, its blue and red emergency strobes piercing the darkness, I thought that perhaps a neighboring camper had summoned him to silence my dissonant guitar strumming beside the campfire. “I’m...

National Academy of Inventors announces two ASU researchers as 2018 Fellows

December 11, 2018

Arizona State University researchers Joshua LaBaer and Nathan Newman have been named Fellows of the National Academy of Inventors, the organization announced today. Election to NAI Fellow status is the highest professional accolade bestowed solely to academic inventors who have demonstrated a prolific spirit of innovation in creating or facilitating outstanding inventions that have made a tangible impact on the quality of life, economic development and welfare of society.  “With...

Biodesign Executive Director Joshua LaBaer appears on 'Arizona Horizon'

December 6, 2018

One quarter of all breast cancers are among people with triple negative HER2 breast cancer. The aggressive form of cancer is caused by a mutation in cells. Dr. Joshua LaBaer, executive director of the Biodesign Institute, and his partner are trying to figure out what is causing those mutations and that would lead to better treatments. He discusses his work on a recent episode of Arizona PBS' "Arizona Horizon." Dr. LaBaer is one of the nation’s foremost investigators in the rapidly...

Biodesign symposium hosts researchers from West China

November 19, 2018

Joshua LaBaer, executive director of the Biodesign Institute, co-hosted a lively and innovative symposium, greeting the international guests in their native language. After enthusiastic applause, the presentations began. The symposium, which hosted representatives from Sichuan University and West China Hospital, in addition to researchers from the Biodesign Institute, focused on exploring strategies for the detection and treatment of infectious diseases and cancer. The gathering...

Expert shares advances and opportunities for genetic editing

November 8, 2018

Genome engineering was the subject of the day as Arizona State University’s Biodesign Institute kicked off a new lecture series designed to bring science’s preeminent thought leaders to ASU. The Arntzen Grand Challenges Lecture Series launched on Nov. 1 with a presentation by Samuel Sternberg, co-author of A Crack in Creation: Gene Editing and the Unthinkable Power to Control Evolution—the premiere text on the emergence and future of genetic editing. CRISPR is a revolutionary tool...

Escape from the lab! Six promising biotech start-up companies profiled at all-day symposium

October 1, 2018

  ASU’s many laboratories are seedbeds for an astonishing variety of new ideas. But the path from basic research to real-world applications can be complex, perilous and sometimes, bewildering. Recently, an all-day seminar, hosted at the Biodesign Institute, explored an array of promising research that has escaped the confines of the lab. New spinout companies, based on pathbreaking research, are bringing exciting innovations in the life sciences to market. The gathering was...

Sino-ASU Biodesign Symposium on Biological Science and Technology

July 17, 2018

Leading experts from the United States and China come together for this full-day symposium to discuss the cutting-edge research and applications in translational research, biological technology, nanomedicine and nanosafety. Host: Biodesign Virginia G. Piper Center for Personalized Diagnostics

National Cancer Institute selects Arizona State University to lead revolutionary research in cancer

June 6, 2018

Arizona State University has been awarded more than $8.5 million over five years from the National Cancer Institute to establish the Arizona Cancer and Evolution Center. The grant will establish ASU as a key player and the hub of an international network of research scientists who are dedicated to understanding cancer in an entirely new way. “The establishment of the Arizona Cancer and Evolution Center at ASU by the National Cancer Institute positions the university at the forefront of new...

Why Biodesign executive director Josh LaBaer is optimistic about cancer, part of ‘A Sip of Science’ series

May 10, 2018

ASU Biodesign Institute executive director Josh LaBaer hosted more than 50 community members May 6 at BLD restaurant in Chandler. LaBaer, a leading cancer researcher and also the executive director of the Biodesign Virginia G. Piper Center for Personalized Diagnostics, walked the crowd through the latest advances in his field. The conversation was the fifth event in Biodesign’s new “Sip of Science” series, which brings top scientists to local restaurants for an open dialogue about...